共 50 条
- [41] Moderately hypofractionated breast radiation therapy: is more evidence needed? LANCET ONCOLOGY, 2019, 20 (05): : E226 - E226
- [42] Assessment of Breast Motion During Hypofractionated Robotic Radiation Therapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S670 - S671
- [43] Hypofractionated Whole Breast Radiation Therapy: Does Size Matter? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S220 - S221
- [45] Acute Toxicity and Quality of Life of Hypofractionated Radiation for Breast Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (05): : 943 - 948
- [46] Outcomes in DCIS Patients Treated with Hypofractionated Whole Breast Radiation Therapy with Integrated Boost Compared to Standard Fractionation with Concomitant Boost INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E580 - E580
- [47] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 384 - 389
- [48] Hypofractionated Whole Breast Radiation in Women with DCIS or Grade 3 Invasive Breast Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S237 - S237
- [50] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 939 - 939